Evidence map›Paper›PMID 29623468›Full record

ArticleVirchows Archiv : an international journal of pathology2018

Misses and near misses in diagnosing nodular fasciitis and morphologically related reactive myofibroblastic proliferations: experience of a referral center with emphasis on frequency of USP6 gene rearrangements.

Ramona Erber, Abbas Agaimy

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 46 citations in OpenAlex.

  1. Intra-Abdominal Sporadic Desmoid Tumors with CanonicalInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Solitary fibrous tumor: an updated review.Journal of pathology and translational medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  9. Nodular fasciitis of the breast: clinicopathologic and molecular characterization with identification of novel USP6 fusion partners.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  10. Recurrent FOS rearrangement in proliferative fasciitis/proliferative myositis.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Ubiquitin-specific Peptidase 6 (Cancer genomics & proteomics
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ramona ErberInstitute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Krankenhausstrasse 8-10, 91054, Erlangen, Germany.
Abbas AgaimyInstitute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Krankenhausstrasse 8-10, 91054, Erlangen, Germany. abbas.agaimy@uk-erlangen.de.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although harmless, reactive and benign neoplastic myo-/fibroblastic proliferations represent a diagnostic challenge in routine surgical pathology practice as reflected by their frequency among consultation cases. In addition to resembling each other, the prototypical nodular fasciitis (NF) and NF-like lesions can be mistaken for low-grade or aggressive sarcomas. USP6 translocation was reported recently as the molecular driver and potential diagnostic marker of NF. We reviewed 71 lesions with a diagnosis of NF (n = 48) or NF-like myofibroblastic proliferations (n = 23) and screened them for USP6 translocation by fluorescence in situ hybridization (FISH). Only one third of NFs were correctly diagnosed by submitting pathologists while one third was initially judged as malignant. NF was mentioned in the differential diagnosis in only half of the cases. A high Ki67/mitotic index, misleading immunohistochemistry (false-positive h-caldesmon), and unusual sites/circumscription were main causes behind overdiagnosis as malignant. FISH analysis revealed USP6 translocation in 74.4% of NF cases. None of the reactive/reparative myofibroblastic proliferations showed USP6 translocation. NF is still significantly misdiagnosed by general surgical pathologists, with a higher tendency toward overdiagnosis of malignancy. Inclusion of NF in the differential diagnosis of any fibromyxoid soft tissue lesion and awareness of its diverse morphology are mandatory to avoid misdiagnoses with the risk of disastrous overtreatment. In the appropriate clinicopathological context, USP6 gene translocation is a valuable adjunct for diagnosis of NF, particularly in limited biopsies. Absence of the USP6 gene translocation in NF-like reparative pseudosarcomatous myofibroblastic proliferations underlines their reactive nature and distinguishes them from NF which is currently considered a benign neoplasm with a self-limiting "transient" growth phase.

Indexed as

Gene RearrangementAdolescentAdultAgedDiagnostic ErrorsFasciitisFemaleHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedMyofibroblastsProto-Oncogene ProteinsUbiquitin ThiolesteraseProto-Oncogene ProteinsUbiquitin ThiolesteraseUSP6 protein, humanFibroma of tendon sheathHeterotopic ossificationMyofibroblastic sarcomaMyositis ossificansMyxofibrosarcomaNodular fasciitisProliferative fasciitisSarcomaUSP6 translocation

Identifiers

PMID29623468
OpenAlexW2795940320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.